Companies: 10,795·Total market cap: $144.5T
Graybug Vision, Inc.

Graybug Vision, Inc.

GRAYNASDAQHealthcare
$5.50
$-0.67(-10.80%)
Market Cap$120983500
P/E Ratio
52W High$20.3
52W Low$4.88

Graybug Vision, Inc. (GRAY) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

gray · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Graybug Vision, Inc. (GRAY) measures how much investors pay for each dollar of the company's trailing earnings. GRAY's current PE ratio of N/A is calculated by dividing its stock price of $5.50 by its TTM earnings per share of -$1.30.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
EPS (TTM)
-$1.30
TTM · diluted EPS
PEG Ratio
0.04
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Graybug Vision, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2018 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Graybug Vision, Inc.
Graybug Vision, Inc.You
GRAY
$121MN/A-$1.30
aTyr Pharma, Inc.
aTyr Pharma, Inc.
ATYR
$43MN/A-$0.80
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.
CYT
$109MN/A-$1.25
Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc.
DBTX
$123MN/A-$2.52
Kinnate Biopharma Inc.
Kinnate Biopharma Inc.
KNTE
$125MN/A-$2.42
NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc.
NGM
$129MN/A-$1.73
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc.
PRTK
$128MN/A-$1.17

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.00
2024-12-31
FY2024
$-0.00
2022-12-31
FY2022
$-23.20
2021-12-31
FY2021
$-23.66
2020-12-31
FY2020
$-58.24
2019-12-31
FY2019
$-35.47
2018-12-31
FY2018
$-2.36

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Graybug Vision, Inc. (GRAY) measures how much investors pay for each dollar of the company's trailing earnings. GRAY's current PE ratio of N/A is calculated by dividing its stock price of $5.50 by its TTM earnings per share of -$1.30.

PE Ratio = Stock Price ÷ EPS (TTM)
= $5.50 ÷ -$1.30 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

GRAY pe ratio · 6 questions

GRAY's current PE ratio is N/A as of 2026-06-08, based on a stock price of $5.50 and TTM EPS of -$1.30. Data sourced from Financial Modeling Prep via GRAY's SEC 10-K and 10-Q filings.

GRAY PE ratioWhat is GRAY PE ratioCurrent PE ratio of GRAYGRAY PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Graybug Vision, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08